These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 29687724)

  • 1. Huntington's disease: Managing neuropsychiatric symptoms in Huntington's disease.
    Loi SM; Walterfang M; Velakoulis D; Looi JC
    Australas Psychiatry; 2018 Aug; 26(4):376-380. PubMed ID: 29687724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.
    Goh AM; Wibawa P; Loi SM; Walterfang M; Velakoulis D; Looi JC
    Australas Psychiatry; 2018 Aug; 26(4):366-375. PubMed ID: 30012004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer disease: Non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms.
    Loi SM; Eratne D; Kelso W; Velakoulis D; Looi JC
    Australas Psychiatry; 2018 Aug; 26(4):358-365. PubMed ID: 29671334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington's disease: a review of the literature on prevalence and treatment of neuropsychiatric phenomena.
    Naarding P; Kremer HP; Zitman FG
    Eur Psychiatry; 2001 Dec; 16(8):439-45. PubMed ID: 11777733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evidence-based approach in the treatment of Huntington's disease.
    Mestre TA; Ferreira JJ
    Parkinsonism Relat Disord; 2012 May; 18(4):316-20. PubMed ID: 22177624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral symptoms associated with Huntington's disease.
    Anderson KE; Marshall FJ
    Adv Neurol; 2005; 96():197-208. PubMed ID: 16383221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntington's Disease: Premotor Phase.
    Ramos ARS; Garrett C
    Neurodegener Dis; 2017; 17(6):313-322. PubMed ID: 29073635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington's disease: clinical presentation and treatment.
    Novak MJ; Tabrizi SJ
    Int Rev Neurobiol; 2011; 98():297-323. PubMed ID: 21907093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the treatment options for Huntington's disease.
    Bonelli RM; Hofmann P
    Expert Opin Pharmacother; 2004 Apr; 5(4):767-76. PubMed ID: 15102562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile Huntington's Disease: Diagnostic and Treatment Considerations for the Psychiatrist.
    Quigley J
    Curr Psychiatry Rep; 2017 Feb; 19(2):9. PubMed ID: 28168595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and psychiatric symptoms associated with Huntington's disease.
    Cummings JL
    Adv Neurol; 1995; 65():179-86. PubMed ID: 7872139
    [No Abstract]   [Full Text] [Related]  

  • 12. A Systematic Review of Neuropsychiatric Symptoms and Functional Capacity in Huntington's Disease.
    Sellers J; Ridner SH; Claassen DO
    J Neuropsychiatry Clin Neurosci; 2020; 32(2):109-124. PubMed ID: 31466515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic approaches to the treatment of Huntington's disease.
    Venuto CS; McGarry A; Ma Q; Kieburtz K
    Mov Disord; 2012 Jan; 27(1):31-41. PubMed ID: 21997232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychiatric problems in a motor disorder: psychosis in Huntington's disease].
    van der Weijde E; Schadé A
    Tijdschr Psychiatr; 2015; 57(3):215-9. PubMed ID: 25856745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.
    Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ
    J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine in motor and mood symptoms of Huntington's disease.
    Shen YC
    World J Biol Psychiatry; 2008; 9(2):147-9. PubMed ID: 17853293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute psychosis in a verified Huntington disease gene carrier with subtle motor signs: psychiatric criteria should be considered for the diagnosis.
    Nagel M; Rumpf HJ; Kasten M
    Gen Hosp Psychiatry; 2014; 36(3):361.e3-4. PubMed ID: 24576988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study using nabilone for symptomatic treatment in Huntington's disease.
    Curtis A; Mitchell I; Patel S; Ives N; Rickards H
    Mov Disord; 2009 Nov; 24(15):2254-9. PubMed ID: 19845035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory Strategies for Huntington's Disease Treatment.
    Colpo GD; Rocha NP; Stimming EF; Teixeira AL
    CNS Neurol Disord Drug Targets; 2017; 16(8):936-944. PubMed ID: 28606048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
    van Duijn E; Craufurd D; Hubers AA; Giltay EJ; Bonelli R; Rickards H; Anderson KE; van Walsem MR; van der Mast RC; Orth M; Landwehrmeyer GB;
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1411-8. PubMed ID: 24828898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.